Agape ATP 2025 Q3 Earnings Net Loss Widens 13.6% Despite Revenue Growth

Agape ATP (ATPC) reported fiscal 2025 Q3 earnings on Nov 13, 2025, showcasing a 11.9% revenue increase to $370,593, outpacing 2024 Q3 figures. However, the company’s net loss expanded to $595,370, marking a 13.6% deterioration year-over-year. Sustained losses over five consecutive quarters highlight persistent financial challenges despite top-line growth.

Revenue

Agape ATP’s total revenue rose to $370,593 in 2025 Q3, driven by robust performance in its core segments. Skin care and health and wellness accounted for the majority of revenue at $369,319, while green energy contributed $1,274. Notably, unallocated expenses remained at $0, reflecting streamlined cost management in this segment. The company’s strategic focus on health and wellness continues to anchor its revenue streams, though the relatively small green energy contribution suggests limited diversification benefits.

Earnings/Net Income

The company narrowed its per-share loss to $0.01 in 2025 Q3, a 92.3% improvement from the $0.13 loss in 2024 Q3. However, the net loss widened to $595,370, representing a 13.6% increase from $524,039 in the prior-year period. This discrepancy underscores rising operating expenses and lower other income, which offset the per-share improvement. Despite a reduction in the magnitude of the loss per share, the company’s net loss widened, underscoring ongoing financial challenges.

Price Action

Agape ATP’s stock price surged 6.15% in the latest trading day, followed by an 11.29% rally over the subsequent full trading week. Month-to-date gains reached 13.11%, reflecting strong short-term investor sentiment.

Post-Earnings Price Action Review

The strategy of purchasing Agape ATP shares after its revenue increase on the financial report release date and holding for 30 days demonstrated favorable performance over the past three years, with a cumulative return of 21.8% and an average annual return of 7.3%. This suggests a solid medium-term investment approach, capturing growth potential post-earnings announcements.

Additional News

Agape ATP’s 10-Q filing for Q3 2025 revealed a strategic pivot toward renewable energy, with new green energy revenue of $1,274 in the quarter. The company also expanded its product portfolio, including the ATP Zeta Health Program and the Easy and Tasty Series (E.A.T.S), aimed at promoting health and wellness through convenient, nutritious solutions. Geographically, the firm emphasized operations in Hong Kong, Malaysia, and China, though it faces tax compliance risks in these jurisdictions. While the 10-Q highlighted efforts to improve financial stability, it cautioned that the success of these initiatives remains uncertain.

CEO Commentary

[No CEO commentary available in the provided data.]

Guidance

[No forward-looking guidance provided in the earnings report or 10-Q filing.]